Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
- PMID: 8483498
- DOI: 10.1038/363156a0
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells
Abstract
Activation of CD4+ T helper cells results from the occupancy of the T-cell receptor (TCR) by immunogenic peptide bound to a class II major histocompatibility complex (MHC) molecule, together with a co-stimulatory signal from the antigen-presenting cell (APC). This activation leads to proliferation, cytokine production (Th1 or Th2 profile) and cytolysis. Engagement of the TCR in the absence of co-stimulation causes Th1 cells to become unresponsive to subsequent antigenic stimulation. We have previously demonstrated that analogues of an immunogenic peptide could stimulate Th1 and Th2 cells to carry out some effector functions without inducing proliferation, a phenomenon we term partial activation. Here we study the consequences of such partial activation through the TCR of two Th1 clones using peptide analogues presented by a live APC. A peptide analogue that is unable to stimulate clonal proliferation or production of cytokine or inositol phosphate can induce the T cells to become profoundly unresponsive to subsequent stimulation with the immunogenic peptide. Thus, altering the ligand of the TCR by using a peptide analogue on a functional APC sends a signal to Th1 clones that results in anergy.
Comment in
-
T cells. Immunological agnosia.Nature. 1993 May 13;363(6425):117-8. doi: 10.1038/363117a0. Nature. 1993. PMID: 8483494 No abstract available.
Similar articles
-
Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.J Immunol. 1996 Apr 15;156(8):2801-8. J Immunol. 1996. PMID: 8609399
-
Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides.J Immunol. 1993 Apr 15;150(8 Pt 1):3131-40. J Immunol. 1993. PMID: 8468461
-
Threshold signaling of human Th0 cells in activation and anergy: modulation of effector function by altered TCR ligand.J Immunol. 2000 Jun 1;164(11):6034-40. doi: 10.4049/jimmunol.164.11.6034. J Immunol. 2000. PMID: 10820288
-
Regulation of T-cell activation: differences among T-cell subsets.Immunol Rev. 1989 Oct;111:79-110. doi: 10.1111/j.1600-065x.1989.tb00543.x. Immunol Rev. 1989. PMID: 2534116 Review.
-
Regulation of T Helper Cell Fate by TCR Signal Strength.Front Immunol. 2020 May 19;11:624. doi: 10.3389/fimmu.2020.00624. eCollection 2020. Front Immunol. 2020. PMID: 32508803 Free PMC article. Review.
Cited by
-
Immune Modulation by Antigenic Peptides and Antigenic Peptide Conjugates for Treatment of Multiple Sclerosis.Med Res Arch. 2022 May;10(5):10.18103/mra.v10i5.2804. doi: 10.18103/mra.v10i5.2804. Epub 2022 Jun 1. Med Res Arch. 2022. PMID: 36381196 Free PMC article.
-
Framework of Intrinsic Immune Landscape of Dormant Prostate Cancer.Cells. 2022 May 5;11(9):1550. doi: 10.3390/cells11091550. Cells. 2022. PMID: 35563856 Free PMC article.
-
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor.J Exp Med. 1994 Jun 1;179(6):1945-56. doi: 10.1084/jem.179.6.1945. J Exp Med. 1994. PMID: 7515103 Free PMC article.
-
Th2 cell clonal anergy as a consequence of partial activation.J Exp Med. 1994 Oct 1;180(4):1195-205. doi: 10.1084/jem.180.4.1195. J Exp Med. 1994. PMID: 7931057 Free PMC article.
-
Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo?Immunol Rev. 1998 Aug;164(1):37-51. doi: 10.1111/j.1600-065x.1998.tb01206.x. Immunol Rev. 1998. PMID: 9795762 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
